NIH BRAIN Initiative
US federal research initiative launched by President Obama in 2013 to develop innovative neurotechnologies and accelerate understanding of the brain. The Brain Research Through Advancing Innovative Neurotechnologies Initiative has invested more than $3.5 billion since 2014 and now operates a 10-year strategic roadmap organised around four Innovation Domains.
Overview
The NIH BRAIN Initiative (Brain Research Through Advancing Innovative Neurotechnologies Initiative) is a US federal research programme launched by President Obama in April 2013 to accelerate development of innovative neurotechnologies and deepen scientific understanding of the brain. The Initiative is administered by the National Institutes of Health and brings together ten NIH Institutes and Centers, academia, industry, and patient communities. It has invested more than $3.5 billion in neuroscience research since 2014.
The Initiative is directed by John Ngai, PhD, who has held the role since March 2020.
Neuroscience Research Roadmap
The Initiative’s 10-year strategic plan, the Neuroscience Research Roadmap, was finalised by the BRAIN Initiative in August 2025 and formally published in the journal Neuron in May 2026, with a joint Director’s Message from John Ngai and Acting NINDS Director Amy Bany Adams on 15 May 2026.
The roadmap is organised around four interconnected Innovation Domains:
-
BRAIN Knowledgebase — an AI-enabled discovery platform integrating molecular, cellular, circuit, and behavioural data across the BRAIN Data Commons, BICAN Brain Cell-Atlas Knowledgebase, CONNECTS Knowledgebase, and BBQS Knowledgebase. The infrastructure already spans nine federated archives holding approximately 12 petabytes of data.
-
Precision Molecular Circuit Therapies — focused on identifying and targeting specific networks of brain cells using genetic delivery systems and engineered control of neural activity, with optogenetic and chemogenetic receptors explicitly named as the effector technologies.
-
Accelerating Human Neuroscience — the bench-to-bedside translation layer, focused on reciprocal application of circuit insights between non-human animal models and humans, advancing invasive and non-invasive measurement methods, and identifying new neuromodulation targets.
-
BRAIN NeuroAI — advancing both neuroscience and AI through bidirectional advances and knowledge exchange, with a phased implementation pipeline of thematic data challenges and seed grants (Phase 1), community benchmarking (Phase 2), and cooperative agreements and public-private partnerships (Phase 3).
Strategic position
The BRAIN Initiative is the central federal research-policy infrastructure for US neuroscience and neurotechnology. The 2026 Neuroscience Research Roadmap arrived during a period of US federal science budget pressure and NINDS leadership transition (Acting Director Amy Bany Adams rather than a permanent appointment), with the Roadmap’s own NeuroAI workshop plan explicitly deferring some implementation steps pending budget clarity. The federal research-policy framing remains structurally distinct from the commercial clinical-stage BCI industry, with the Roadmap notably not naming Neuralink, Synchron, Paradromics, Precision Neuroscience, or any other commercial-stage BCI company.